Data dictionary: Breast Implants - DBIR
From Beacon
Go back to Dutch Institute for Clinical Auditing Databases (DICA) (The Netherlands) page.
This is a summary of the variables available in the database. You can download the complete data dictionary. Click here to learn more.
Table 1: Patient Identification.
| Variables |
|---|
| Hospital |
| Local patient identification number |
| Unique patient number, clinic |
Table 2: Patient Demographics.
| Variables |
|---|
| Date of birth |
| Sex |
Table 3: Cosmetic Surgery Information.
| Variables |
|---|
| First bilateral cosmetic augmentation? (If you select “yes”, some answers will be prefilled. Please check carefully if these answers apply to your patient and complete remaining questions.) |
| Is this a first cosmetic augmentation where a new implant is inserted bilaterally? |
| Side of operation |
| Operation date |
| Indication of surgery |
| Previous radiotherapy |
| First implant surgery of this breast |
Table 4: Medical and Surgical Details.
| Variables |
|---|
| What is the ASA classification before operation |
| Nicotine abuse |
| Height in centimeters |
| Weight in kilograms |
| BMI |
| Intervention |
| Replacement of device with autologous tissue |
Table 5: Implant Information.
| Variables |
|---|
| Incision site |
| Plane (of re-insertion) |
| Capsulectomy |
| Manufacturer ADM |
| Manufacturer MESH |
| Mastopexy |
| Autologous flap cover |
| Fat grafting |
| Preoperative antibiotics |
| Postoperative antibiotics |
| Rinse of the pocket |
| Rinse of the pocket type |
| Sleeve/funnel |
| Nipple guards |
| Glove change for insertion |
| Drains |
| Planned replacement of TE with permanent implant |
| Planned replacement of TE for autologous reconstruction |
Table 6: Postoperative Complications.
| Variables |
|---|
| Problem at contralateral side (no complications on this side) |
| Deep wound infections |
| Skin necrosis or dehiscence |
| Seroma |
| Hematoma |
| Autologous flap problem (e.g., LD) |
| Skin scarring problems |
| Capsular contracture |
| Capsular contracture grade |
| Breast pain |
| Patient dissatisfied with volume |
| Asymmetry |
| Newly diagnosed breast cancer |
| Suspicion of BIA-ALCL |
| PA confirmed BIA-ALCL |
| Patient's request without health complaints |
| Suspicion of breast implant-associated illness (previously ASIA) |
| Device rupture or Device deflation |
| Silicone extravasation |
| Silicone extravasation type |
| Device Malposition |
| Recall |
| Other (describe) |
| Seroma/Hematoma |
Table 7: Device Details.
| Variables |
|---|
| Is the device inserted or removed? |
| Is the current device already registered by this hospital in the DBIR? |
| Insertion type |
| Year of implantation (yyyy) |
| Medical records or device passport |
| Identifiable markers on implant |
| Reference No |
| Manufacturer |
| Device type |
| Texture |
| Coating |
| Fill |
| Shape |
| (Maximum) weight/volume of implant (cc or gr) |
| Manufacturer supports barcode |
| Using GS1 barcode scanner? |
| GS1 barcode. Code starts with (01) |
| Barcode Processing Status |
| GTIN (= global trade item number) |
| Expiry Date (YYMMDD) |
| Lot Number |
| Serial Number |
Table 8: SARS-CoV-2 Infection Information.
| Variables |
|---|
| Was there (clinical) suspicion of or a test performed for a SARS-CoV-2 infection in the period before admission up until 30 days after admission? |
| Date of admission or, if not available, date of treatment |
| Has the patient been tested for SARS-CoV-2 infection using a chest CT, RT-PCR or another specific lab test? |
| On what date was the first suspicion of SARS-CoV-2 infection? [ICD-10: U07.2 date] |
| If unknown: Was this before treatment or during / after treatment? |
| On what date was the first specific test performed for SARS-CoV-2 infection? [ICD-10: U07.1 or U07.2 date] |
| If unknown: Was this before treatment or during / after treatment? |
| On what date was the first positive lab test on SARS-CoV-2? [ICD-10: U07.1 date] |
| If unknown: Was this before treatment or during / after treatment? |
| Date and time of admission to ICU |
| Date and time of discharge from ICU |
| Destination after discharge from ICU |
| What was the final status regarding SARS-CoV-2? |
